Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Sensors (Basel) ; 19(21)2019 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-31684205

RESUMO

This work presents a novel technique for designing chipless radio frequency identification (RFID) tags which, unlike the traditional tags with complex geometries, are both compact and printable. The tags themselves are alphabets, which offers the advantage of efficient visual recognition of the transmitted data in real-time via radio frequency (RF) waves. In this study, the alphabets (e.g., a, b and c) are realized by using copper etching on a thin dielectric substrate (TLX-8) backed by a ground plane. It is shown that the original signature of the frequency response of the backscattered radar cross-section (RCS) of the letter, displays dips that are unique to the individual letters. The tags have been simulated, fabricated and their monostatic cross-sections have been measured by using a dual-polarized Vivaldi antenna in the frequency band ranging from 6 to 13 GHz. The study also includes, for the first time, a detailed analysis of the impact of changing the shape of the tag owing to variation in the font type, size, spacing, and orientation. The proposed letters of the alphabet are easily printable on the tag and provide an efficient way to visually recognized them and, hence, to detect them in a robust way, even with a low coding density of 2.63 bit/cm2. The advantages of the proposed novel identification method, i.e., utilization of the both co- and cross-polar RCS characteristics for the printable clipless RFID tags are the enhancement of the coding density, security and better detection of the alphabet tags with different fonts by capturing the tag characteristics with better signal to noise ratio (SNR). Good agreement has been achieved between the measured and simulated results for both co- and cross-polarized cases.

2.
Biomed Eng Online ; 10: 82, 2011 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-21936884

RESUMO

BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder resulting in motor disturbances that can impact normal gait. Although PD initially responds well to pharmacological treatment, as the disease progresses efficacy often fluctuates over the course of the day, and clinical management would benefit from long-term objective measures of gait. We have previously described a small device worn on the shank that uses acceleration and angular velocity sensors to calculate stride length and identify freezing of gait in PD patients. In this study we extend validation of the gait monitor to 24-h using simultaneous video observation of PD patients. METHODS: A sleep laboratory was adapted to perform 24-hr video monitoring of patients while wearing the device. Continuous video monitoring of a sleep lab, hallway, kitchen and conference room was performed using a 4-camera security system and recorded to hard disk. Subjects (3) wore the gait monitor on the left shank (just above the ankle) for a 24-h period beginning around 5 pm in the evening. Accuracy of stride length measures were assessed at the beginning and end of the 24-h epoch. Two independent observers rated the video logs to identify when subjects were walking or lying down. RESULTS: The mean error in stride length at the start of recording was 0.05 m (SD 0) and at the conclusion of the 24 h epoch was 0.06 m (SD 0.026). There was full agreement between observer coding of the video logs and the output from the gait monitor software; that is, for every video observation of the subject walking there was a corresponding pulse in the monitor data that indicated gait. CONCLUSIONS: The accuracy of ambulatory stride length measurement was maintained over the 24-h period, and there was 100% agreement between the autonomous detection of locomotion by the gait monitor and video observation.


Assuntos
Marcha , Monitorização Ambulatorial/métodos , Doença de Parkinson/fisiopatologia , Aceleração , Idoso , Feminino , Humanos , Levodopa/uso terapêutico , Masculino , Doença de Parkinson/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA